Telix Pharmaceuticals Ltd. (AU:TLX) has released an update.
Telix Pharmaceuticals Ltd. announced the departure of Dr. Andreas Kluge from its board, effective October 17, 2024. Dr. Kluge, through Gnosis Verwaltungsgesellschaft m.b.H, holds 22,675,000 fully paid ordinary shares, indicating significant past involvement with the company. This change may influence investor perceptions and future strategic directions for Telix.
For further insights into AU:TLX stock, check out TipRanks’ Stock Analysis page.
